K&G Techlaw Partners
Practice AreasNewsBlogVideosWebinars
About K&G TechlawOur Team
Enquire
Practice AreasNewsBlogVideosWebinars

About

About K&G TechlawOur Team
Enquire
HomeNews

24 August 2026|MedTech

Centre eases medical device rules for sterilisation

The Centre has amended the Medical Devices Rules, 2017 to ease requirements for manufacturers that outsource sterilisation, removing the need for a separate loan licence where the sterilisation facility already holds a valid licence.

Source
Share this News:

Related News

  • 8 September 2026

    CBIC introduces mandatory compliance checklists for drugs, cosmetics, medical devices and IVDs imports
  • 2 September 2026

    Adverse event reporting manual for medical devices issued by Indian Pharmacopoeia Commission
  • 2 September 2026

    Government introduces Ninth Schedule setting fees for medical device testing and evaluation
  • 1 September 2026

    QMS requirements clarified for Class A NSNM medical devices
  • 1 September 2026

    Government plans domestic ecosystem for advanced medical device manufacturing
All Related News

Related Articles

  • 9 July 2026

    Medical Devices (Amendment) Rules, 2026: How CDSCO’s Faster Licensing Timelines Reshape Manufacturing Compliance
  • 9 July 2026

    Jan Vishwas 2.0: What the New Decriminalisation Law Means for the Pharma Industry
  • 3 July 2026

    DPCO Amendment 2026: What NPPA’s New Overcharging and Compliance Rules Mean for Pharma Companies
  • 1 July 2026

    Form 11 Drug Import India: CDSCO’s 2026 Proposed Amendment Explained for Pharma Companies
  • 27 June 2026

    Schedule K Amendment: What the Deletion of ‘Syrup’ Really Means for India’s Drug Retail Landscape
All Articles

Are you looking for someone to help?

  • +91 9820169210
  • info@kngtechlaw.com
  • 09:00 - 17:00
Contact us
K&G Techlaw Partners

In the ever-evolving world of Pharma and Healthcare, K&G Techlaw Partners is at the forefront of providing legal support to businesses.

Follow us

  • LinkedIn
  • Facebook

K&G Techlaw

  • Practice Areas
  • News
  • Blog
  • About K&G Techlaw
  • Our Team
  • Contact Us
  • Disclaimer

Offices

Supreme Court chamber

Chamber No. 402, 4th Floor Block D, Lawyers Chamber Block, Additional Building Complex, Supreme Court of India, New Delhi - 110001

Faridabad

B-502, Kanishka Tower, Sector 34, Faridabad - 121003

Tel: +91 9820169210, +91 9766910499, +91 7905747692

Email: info@kngtechlaw.com

Copyright © 2026 K&G Techlaw Partners. All rights reserved.

Privacy PolicyTerms and ConditionsDisclaimer
K&G Techlaw Partners

Disclaimer

As per the rules of the Bar Council of India, K&G Techlaw Partners (the “Firm”) is prohibited from soliciting work or advertising. By clicking “I Agree” below, you acknowledge that:

  1. There has been no advertisement, personal communication, solicitation, invitation or inducement of any sort whatsoever from the Firm or any of its members to solicit any work or advertise through this website.
  2. The purpose of this website is to provide the user with information about the Firm, its practice areas, its advocates and solicitors.
  3. The user wishes to gain more information about the Firm for his/her own information and personal/professional use.
  4. The information about the Firm is provided to the user only on his/her specific request and any information obtained or materials downloaded from this website are completely at the user’s volition and any transmission, receipt or use of this website would not create any lawyer-client relationship.
  5. This website is not intended to be a source of advertising or solicitation, and the contents hereof should not be construed as legal advice in any manner whatsoever.
  6. The Firm is not liable for any consequence of any action taken by the user relying on material/information provided under this website. In cases where the user requires any assistance, he/she must seek independent legal advice.
  7. The content of this website is Intellectual Property of the Firm.

Please read and accept our Terms and Conditions and our Privacy Policy before proceeding.

I have read, understood, and agree to the above disclaimer in its entirety.